[18F]Fluorodeoxyglucose PET in Large Vessel Vasculitis

PET Clinics

Volumn 1, Issue 2, 2006, Pages 179-189

  Walter, Martin A ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 64749104003     PISSN: 15568598     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cpet.2006.02.001     Document Type: Review

References (64)

1. Rohren E.M., Turkington T.G., and Coleman R.E. Clinical applications of PET in oncology. Radiology 231 2 (2004) 305-332
2. Turlakow A., Yeung H.W., Pui J., et al. Fludeoxyglucose positron emission tomography in the diagnosis of giant cell arteritis. Arch Intern Med 161 7 (2001) 1003-1007
3. Blockmans D., Van Moer E., Dehem J., et al. Positron emission tomography can reveal abdominal periaortitis. Clin Nucl Med 27 3 (2002) 211-212
4. Wenger M., Gasser R., Donnemiller E., et al. Images in cardiovascular medicine. Generalized large vessel arteritis visualized by 18 fluorodeoxyglucose-positron emission tomography. Circulation 107 6 (2003) 923
5. Brodmann M., Lipp R.W., Aigner R., et al. Positron emission tomography reveals extended thoracic and abdominal peri-aortitis. Vasc Med 8 2 (2003) 127-128
6. Wiest R., Gluck T., Schonberger J., et al. Clinical image: occult large vessel vasculitis diagnosed by PET imaging. Rheumatol Int 20 6 (2001) 250
7. De Winter F., Petrovic M., Van de Wiele C., et al. Imaging of giant cell arteritis: evidence of splenic involvement using FDG positron emission tomography. Clin Nucl Med 25 8 (2000) 633-634
8. Hara M., Goodman P.C., and Leder R.A. FDG-PET finding in early-phase Takayasu arteritis. J Comput Assist Tomogr 23 1 (1999) 16-18
9. Malik I.S., Harare O., Al-Nahhas A., et al. Takayasu's arteritis: management of left main stem stenosis. Heart 89 3 (2003) e9
10. Walter M.A., Melzer R.A., Graf M., et al. [18F]FDG-PET of giant-cell aortitis. Rheumatology (Oxford) 44 5 (2005) 690-691
11. Hutchinson J. On a peculiar form of thrombotic arteritis of the aged which is sometimes productive or gangrene. Arch Surg 1 (1890) 323-329
12. Klein R.G., Hunder G.G., Stanson A.W., et al. Large artery involvement in giant cell (temporal) arteritis. Ann Intern Med 83 6 (1975) 806-812
13. Salvarani C., Gabriel S.E., O'Fallon W.M., et al. The incidence of giant cell arteritis in Olmsted County, Minnesota: apparent fluctuations in a cyclic pattern. Ann Intern Med 123 3 (1995) 192-194
14. Franzen P., Sutinen S., and von Knorring J. Giant cell arteritis and polymyalgia rheumatica in a region of Finland: an epidemiologic, clinical and pathologic study, 1984-1988. J Rheumatol 19 2 (1992) 273-276
15. Gonzalez-Gay M.A., Alonso M.D., Aguero J.J., et al. Giant cell arteritis in Mediterranean countries: comment on the article by Salvarani et al. Arthritis Rheum 35 10 (1992) 1249-1250
16. Ostberg G. An arteritis with special reference to polymyalgia arteritica. Acta Pathol Microbiol Scand [A] 237 Suppl 237 (1973) 1-59
17. Lie J.T. Illustrated histopathologic classification criteria for selected vasculitis syndromes. American College of Rheumatology Subcommittee on Classification of Vasculitis. Arthritis Rheum 33 8 (1990) 1074-1087
18. Weyand C.M. The Dunlop-Dottridge Lecture: the pathogenesis of giant cell arteritis. J Rheumatol 27 2 (2000) 517-522
19. Salvarani C., Macchioni P.L., Tartoni P.L., et al. Polymyalgia rheumatica and giant cell arteritis: a 5-year epidemiologic and clinical study in Reggio Emilia, Italy. Clin Exp Rheumatol 5 3 (1987) 205-215
20. Huston K.A., and Hunder G.G. Giant cell (cranial) arteritis: a clinical review. Am Heart J 100 1 (1980) 99-105
21. Calamia K.T., and Hunder G.G. Giant cell arteritis (temporal arteritis) presenting as fever of undetermined origin. Arthritis Rheum 24 11 (1981) 1414-1418
22. Takayasu M. Case with unusual changes of the central vessels in the retina. Acta Soc Ophthal Jpn 12 (1908) 554-555
23. Waern A.U., Andersson P., and Hemmingsson A. Takayasu's arteritis: a hospital-region based study on occurrence, treatment and prognosis. Angiology 34 5 (1983) 311-320
24. Hall S., Barr W., Lie J.T., et al. Takayasu arteritis. A study of 32 North American patients. Medicine (Baltimore) 64 2 (1985) 89-99
25. el-Reshaid K., Varro J., al-Duwairi Q., et al. Takayasu's arteritis in Kuwait. J Trop Med Hyg 98 5 (1995) 299-305
26. Lande A. Abdominal Takayasu's aortitis, the middle aortic syndrome and atherosclerosis. A critical review. Int Angiol 17 1 (1998) 1-9
27. Nasu T. Pathology of pulseless disease. A systematic study and critical review of twenty-one autopsy cases reported in Japan. Angiology 14 (1963) 225-242
28. Matsunaga N., Hayashi K., Sakamoto I., et al. Takayasu arteritis: protean radiologic manifestations and diagnosis. Radiographics 17 3 (1997) 579-594
29. Moriwaki R., Noda M., Yajima M., et al. Clinical manifestations of Takayasu arteritis in India and Japan: new classification of angiographic findings. Angiology 48 5 (1997) 369-379
30. Hunder G.G., Bloch D.A., Michel B.A., et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 33 8 (1990) 1122-1128
31. Arend W.P., Michel B.A., Bloch D.A., et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum 33 8 (1990) 1129-1134
32. Rao J.K., Allen N.B., and Pincus T. Limitations of the 1990 American College of Rheumatology classification criteria in the diagnosis of vasculitis. Ann Intern Med 129 5 (1998) 345-352
33. Salvarani C., and Hunder G.G. Giant cell arteritis with low erythrocyte sedimentation rate: frequency of occurrence in a population-based study. Arthritis Rheum 45 2 (2001) 140-145
34. Hayreh S.S., and Zimmerman B. Management of giant cell arteritis. Our 27-year clinical study: new light on old controversies. Ophthalmologica 217 4 (2003) 239-259
35. Gonzalez-Gay M.A., Garcia-Porrua C., Salvarani C., et al. The spectrum of conditions mimicking polymyalgia rheumatica in Northwestern Spain. J Rheumatol 27 9 (2000) 2179-2184
36. Lambert M., Hachulla E., Hatron P.Y., et al. [Takayasu's arteritis: vascular investigations and therapeutic management. Experience with 16 patients]. Rev Med Interne 19 12 (1998) 878-884 [in French]
37. Lambert M., Hatron P.Y., Hachulla E., et al. Takayasu's arteritis diagnosed at the early systemic phase: diagnosis with noninvasive investigation despite normal findings on angiography. J Rheumatol 25 2 (1998) 376-377
38. Ishimori T., Saga T., Mamede M., et al. Increased (18)F-FDG uptake in a model of inflammation: concanavalin A-mediated lymphocyte activation. J Nucl Med 43 5 (2002) 658-663
39. Jones H.A., Cadwallader K.A., White J.F., et al. Dissociation between respiratory burst activity and deoxyglucose uptake in human neutrophil granulocytes: implications for interpretation of (18)F-FDG PET images. J Nucl Med 43 5 (2002) 652-657
40. Schelbert H.R., Hoh C.K., Royal H.D., et al. Procedure guideline for tumor imaging using fluorine-18-FDG. Society of Nuclear Medicine. J Nucl Med 39 7 (1998) 1302-1305
41. Bombardieri E., Aktolun C., Baum R.P., et al. FDG-PET: procedure guidelines for tumour imaging. Eur J Nucl Med Mol Imaging 30 12 (2003) BP115-BP124
42. Andrews J., Al-Nahhas A., Pennell D.J., et al. Non-invasive imaging in the diagnosis and management of Takayasu's arteritis. Ann Rheum Dis 63 8 (2004) 995-1000
43. Webb M., Chambers A., Al-Nahhas A., et al. The role of 18F-FDG PET in characterising disease activity in Takayasu arteritis. Eur J Nucl Med Mol Imaging 31 5 (2004) 627-634
44. Bleeker-Rovers C.P., Bredie S.J., van der Meer J.W., et al. F-18-fluorodeoxyglucose positron emission tomography in diagnosis and follow-up of patients with different types of vasculitis. Neth J Med 61 10 (2003) 323-329
45. Brodmann M., Lipp R.W., Passath A., et al. The role of 2-18F-fluoro-2-deoxy-D-glucose positron emission tomography in the diagnosis of giant cell arteritis of the temporal arteries. Rheumatology (Oxford) 43 2 (2004) 241-242
46. Moosig F., Czech N., Mehl C., et al. Correlation between 18-fluorodeoxyglucose accumulation in large vessels and serological markers of inflammation in polymyalgia rheumatica: a quantitative PET study. Ann Rheum Dis 63 7 (2004) 870-873
47. Meller J., Strutz F., Siefker U., et al. Early diagnosis and follow-up of aortitis with [(18)F]FDG PET and MRI. Eur J Nucl Med Mol Imaging 30 5 (2003) 730-736
48. Walter M.A., Melzer R.A., Schindler C., et al. The value of [18F]FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease. Eur J Nucl Med Mol Imaging 32 6 (2005) 674-681
49. Kobayashi Y., Ishii K., Oda K., et al. Aortic wall inflammation due to Takayasu arteritis imaged with 18F-FDG PET coregistered with enhanced CT. J Nucl Med 46 6 (2005) 917-922
50. Blockmans D., Stroobants S., Maes A., et al. Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: evidence for inflammation of the aortic arch. Am J Med 108 3 (2000) 246-249
51. Meller J., Grabbe E., Becker W., et al. Value of F-18 FDG hybrid camera PET and MRI in early Takayasu aortitis. Eur Radiol 13 2 (2003) 400-405
52. Scheel A.K., Meller J., Vosshenrich R., et al. Diagnosis and follow up of aortitis in the elderly. Ann Rheum Dis 63 11 (2004) 1507-1510
53. Kroger K., Antoch G., Goyen M., et al. Positron emission tomography/computed tomography improves diagnostics of inflammatory arteritis. Heart Vessels 20 4 (2005) 179-183
54. Antoch G., Freudenberg L.S., Debatin J.F., et al. Images in vascular medicine. Diagnosis of giant cell arteritis with PET/CT. Vasc Med 8 4 (2003) 281-282
55. Rudd J.H., Warburton E.A., Fryer T.D., et al. Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. Circulation 105 23 (2002) 2708-2711
56. Yun M., Yeh D., Araujo L.I., et al. F-18 FDG uptake in the large arteries: a new observation. Clin Nucl Med 26 4 (2001) 314-319
57. Yun M., Jang S., Cucchiara A., et al. 18F FDG uptake in the large arteries: a correlation study with the atherogenic risk factors. Semin Nucl Med 32 1 (2002) 70-76
58. Kerr G.S., Hallahan C.W., Giordano J., et al. Takayasu arteritis. Ann Intern Med 120 11 (1994) 919-929
59. Sachelarie I., Kerr K., Ghesani M., et al. Integrated PET-CT: evidence-based review of oncology indications. Oncology (Williston Park) 19 4 (2005) 481-490
60. Macapinlac H.A. FDG PET and PET/CT imaging in lymphoma and melanoma. Cancer J 10 4 (2004) 262-270
61. Frank S.J., Chao K.S., Schwartz D.L., et al. Technology insight: PET and PET/CT in head and neck tumor staging and radiation therapy planning. Nat Clin Pract Oncol 2 10 (2005) 526-533
62. Blockmans D., Maes A., Stroobants S., et al. New arguments for a vasculitic nature of polymyalgia rheumatica using positron emission tomography. Rheumatology (Oxford) 38 5 (1999) 444-447
63. Blockmans D., Baeyens H., Van Loon R., et al. Periaortitis and aortic dissection due to Wegener's granulomatosis. Clin Rheumatol 19 2 (2000) 161-164
64. Belhocine T., Kaye O., Delanaye P., et al. [Horton's disease and extra-temporal vessel locations: role of 18FDG PET scan. Report of 3 cases and review of the literature]. Rev Med Interne 23 7 (2002) 584-591 [in French]